Drug intelligence / Profile preview

Type J collagen peptide

Development stage: Unknown
Lead developer: Nitta Gelatin
Modality: Peptides
Administration: Oral

Overview

Type J collagen peptide, marketed under the brand name Wellnex, is a high-functional bovine collagen peptide developed by Nitta Gelatin India Limited and Nitta Gelatin Inc. It is characterized by enhanced levels of active dipeptides, specifically proline-hydroxyproline (PO) and hydroxyproline-glycine (OG), exceeding 3,000 ppm, and has an average molecular weight of less than 1,000 Da, significantly lower than conventional collagen peptides. This nutritional supplement is primarily indicated for the management of knee joint osteoarthritis, where it acts to reduce pain, improve functional capacity, and slow disease progression.

Brand names: WellnexWellnex Replenwell
Other names: high-functional bovine collagen peptides

Targets

FMOD (Fibromodulin / FMOD)

Beyond the preview

Go deeper on Type J collagen peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type J collagen peptide.

Explore the full profile